ISEE IVERIC bio Inc

Price (delayed)

$6.14

Market cap

$549.94M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.26

Enterprise value

$427.26M

Sector: Healthcare
Industry: Biotechnology

Highlights

The debt has dropped by 83% year-on-year and by 10% since the previous quarter
ISEE's EPS has dropped by 169% year-on-year but it is up by 6% since the previous quarter
The equity has soared by 140% YoY but it has decreased by 10% from the previous quarter
IVERIC bio's net income has decreased by 17% from the previous quarter

Key stats

What are the main financial stats of ISEE
Market
Shares outstanding
89.57M
Market cap
$549.94M
Enterprise value
$427.26M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.56
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$80.28M
EBITDA
-$80.14M
Free cash flow
-$56.94M
Per share
EPS
-$1.26
Free cash flow per share
-$0.61
Book value per share
$2.4
Revenue per share
$0
TBVPS
$2.53
Balance sheet
Total assets
$234.6M
Total liabilities
$20.01M
Debt
$130,000
Equity
$214.59M
Working capital
$214.47M
Liquidity
Debt to equity
0
Current ratio
11.76
Quick ratio
11.59
Net debt/EBITDA
1.53
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-41.9%
Return on equity
-45.4%
Return on invested capital
-438.6%
Return on capital employed
-37.4%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ISEE stock price

How has the IVERIC bio stock price performed over time
Intraday
2.16%
1 week
-2.85%
1 month
11.64%
1 year
10.23%
YTD
-11.14%
QTD
-11.14%

Financial performance

How have IVERIC bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$81.08M
Net income
-$76.59M
Gross margin
N/A
Net margin
N/A
The operating income is down by 24% YoY and by 15% from the previous quarter
IVERIC bio's net income has decreased by 17% from the previous quarter

Growth

What is IVERIC bio's growth rate over time

Valuation

What is IVERIC bio stock price valuation
P/E
N/A
P/B
2.56
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ISEE's EPS has dropped by 169% year-on-year but it is up by 6% since the previous quarter
The equity has soared by 140% YoY but it has decreased by 10% from the previous quarter
The stock's price to book (P/B) is 28% more than its last 4 quarters average of 2.0

Efficiency

How efficient is IVERIC bio business performance
ISEE's return on assets has dropped by 179% year-on-year but it is up by 5% since the previous quarter
ISEE's return on equity has dropped by 178% year-on-year but it is up by 5% since the previous quarter

Dividends

What is ISEE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ISEE.

Financial health

How did IVERIC bio financials performed over time
The total assets has surged by 137% year-on-year but it has declined by 6% since the previous quarter
IVERIC bio's total liabilities has surged by 114% YoY and by 68% QoQ
The debt is 100% smaller than the equity
The equity has soared by 140% YoY but it has decreased by 10% from the previous quarter
The debt has dropped by 83% year-on-year and by 10% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.